$CMPR

CIMPRESS plc (CMPR): Results of Operations and Financial Condition

CIMPRESS plc (CMPR) filed an SEC Form 8-K — Results of Operations and Financial Condition. cmpr-20260729 0001262976 false 0001262976 2024-10-30 2024-10-30 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________ Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date o

Original reporting
Published Jul 29, 2026, 8:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 8:20 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$CMPR
Neutral
low confidence
Mentioned
$CMPR
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CMPRNeutralLow
01

Why it matters

The filing itself is procedural, but it flags that the earnings document is available, which is the likely source of any new information for CMPR’s valuation.

02

Market read

This is the earnings-release trigger for CMPR, but the scrape does not include the actual results or guidance needed to assess direction.

03

What to watch

Traders should verify Exhibit 99.1 for guidance, margin drivers, and any restructuring or demand commentary, since those are typically what move CMPR.

Relevance 7/10Novelty 3/10Timing: after-hours filing on July 29, 2026, tied to Q4 and fiscal 2026 results release

Background

The company used Item 2.02 to announce that it posted its Q4 and fiscal year 2026 quarterly earnings document on its website and furnished it as Exhibit 99.1.

Company-level read

Ticker impact

$CMPRNeutralLow confidence
Context

Cimpress filed an 8-K stating it posted its Q4 and fiscal 2026 earnings document for the quarter and year ended June 30, 2026.

Expected impact

Potential volatility around the earnings exhibit details (revenue, margins, guidance), but the provided text contains no numbers to confirm direction.

Evidence & confidence

The 8-K text only describes that Exhibit 99.1 was furnished; it does not include the actual financial results or guidance, so directional impact cannot be inferred from the scrape.

Market effects

Limited from this scrape, since no segment or outlook details are provided.

Limited from this scrape; no regional demand or currency commentary is included.

Limited from this scrape; no macro or cross-border contract details are included.

Counterpoint

Because the scrape omits Exhibit 99.1 content, the market reaction may be driven by specifics not visible here, so treating this as a low-signal item could miss the real catalyst.

Key entities

  • Cimpress plc

    Subject issuer filing an 8-K for Q4 and fiscal year 2026 results, with Exhibit 99.1 containing the earnings document.

Related articles

$CMPRMedAI 8/10

Cimpress (NASDAQ:CMPR) Reaches New 52

Cimpress plc (NASDAQ:CMPR) hit a new 52-week high on Tuesday, trading up to $105.00 and last at $104.94 versus a prior close of $102.39. The article also cites recent analyst actions: Zacks downgraded to “hold,” while Truist set a $110 target and Barrington raised its to $113. On April 29, Cimpress reported Q1 EPS of $0.55 and revenue of $886.21M.

$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.

$GSBDMed

Goldman Sachs BDC Q2 Earnings Call Highlights

Goldman Sachs BDC (NYSE:GSBD) reported no incentive fee in Q2, citing its three-year total-return lookback provision. NAV was $12.06/share at June 30 vs $12.17 in Q1. The board declared a Q3 base dividend of $0.32/share plus $0.03 supplemental. Investments were $3.2B fair value, non-accrual 2.9%, and net debt-to-equity 1.35x.

$HBBMed

Hamilton Beach Brands Q2 Earnings Call Highlights

Hamilton Beach Brands (HBB) reported Q2 gross margin of 26.1% excluding tariff-related benefits, and said it expects 2026 revenue growth in the mid-single-digit range. Management forecast full-year gross margin to improve modestly and operating profit to decline by a high-single-digit percentage. Operating cash flow is expected at $35M to $45M. HBB ended with net cash of $51.5M.

$GXOMed

GXO Logistics Q2 Earnings Call Highlights

GXO Logistics reported Q2 results and said it secured over $1 billion in expected incremental new-business revenue for 2026 and about $353 million for 2027. Management cited a $2.7 billion sales pipeline after quarter end. Operating cash flow was $76 million, free cash flow positive $12 million, cash $769 million, and net leverage 2.6x. GXO plans to target EBIT margins above 6% and deploy AI across ~50 sites in 2026.

$GRNDMed

Grindr Q2 Earnings Call Highlights

Grindr (NYSE:GRND) said free users remain central to its strategy, while AI tools are boosting engineering productivity. Management estimated engineering output rose about 2.5x from July 2025 to April 2026 with similar headcount, supporting a 39% to 42% adjusted EBITDA margin outlook. EDGE AI premium tier rollout is planned for later in fall; operating expenses ex cost of revenue were $71M vs $53M.